Samplix
Samplix provides the Xdrop microfluidic platform, which encapsulates individual cells in double-emulsion droplets for high-throughput functional single-cell analysis. The platform is compatible with standard flow cytometers and sorters, enabling researchers to measure secretion, cell-cell interactions, and cytotoxicity while preserving cell viability for downstream recovery and analysis.
- Biotechnology
- Drug Discovery & Therapeutics
- Hardware
Funding
Raised to date
€3MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Est. $3.3Macross 1 round
€3M · Undisclosed Tranche
Announced Oct 2026
Disclosed cumulative: $3.3M
Founders
Founder details are not available yet.
Product
Problem
Traditional bulk assays mask cellular heterogeneity and miss rare, high-value functional cells. Researchers cannot reliably link functional behavior—such as secretion, interactions, or cytotoxicity—to specific individual cells, limiting the discovery of high-performing cells in antibody discovery and immunotherapy research.
Solution
Samplix provides the Xdrop microfluidic platform, which encapsulates individual cells in highly uniform double-emulsion droplets that are compatible with standard flow cytometers and cell sorters. These droplets act as isolated microreactors, allowing researchers to measure secreted antibodies, cytokines, and other proteins at true single-cell resolution while preserving cell viability for downstream applications. The aqueous-phase droplet format eliminates the need for specialized detection systems, enabling scientists to integrate droplet-based workflows directly into existing laboratory infrastructure. Xdrop supports functional screening of cell–cell interactions, cell killing assays, and analysis of cellular heterogeneity, empowering immunotherapy and antibody discovery research.
Target Audience
Primary customers are academic and industrial researchers in antibody discovery, immunotherapy development, and single-cell functional analysis who need high-throughput screening of live cells using existing flow cytometry infrastructure.
Features
- Double-emulsion droplet generation producing highly uniform, stable microreactors dispersed in aqueous phase for flow cytometer and sorter compatibility
- Single-cell functional assays for secreted antibodies, cytokines, and other proteins confined within droplets
- Cell–cell interaction and cytotoxicity (cell killing) assay capabilities for immunotherapy research
- Cell viability preservation enabling recovery and downstream use of sorted cells
- Integration with standard flow cytometers and sorters without specialized detection systems
- Scalable, reproducible single-cell experimentation across secretion assays, functional screening, and heterogeneity analysis